LJMU Research Online
暂无分享,去创建一个
Helena | E. Yates | T. Rudd | Maria C. Z. Meneghetti | Ashley J. Hughes | M. Lima | A. Powell | Andrew K. Powell | B. Náder | Ashley J. Hughes | Edwin A. Yates | Marcelo A. Lima | Helena | B. Nader
[1] G. Balogh,et al. Dynamic properties of the native free antithrombin from molecular dynamics simulations: computational evidence for solvent- exposed Arg393 side chain , 2015, Journal of biomolecular structure & dynamics.
[2] J. Turnbull,et al. Heparan sulfate phage display antibodies recognise epitopes defined by a combination of sugar sequence and cation binding. , 2015, Organic & biomolecular chemistry.
[3] F. Lamari,et al. HS3ST2 expression is critical for the abnormal phosphorylation of tau in Alzheimer's disease-related tau pathology. , 2015, Brain : a journal of neurology.
[4] Marco Rusnati,et al. Heparin/Heparan Sulfate Proteoglycans Glycomic Interactome in Angiogenesis: Biological Implications and Therapeutical Use , 2015, Molecules.
[5] P. Meikle,et al. Distribution of Heparan Sulfate Oligosaccharides in Murine Mucopolysaccharidosis Type IIIA , 2014, Metabolites.
[6] A. Imberty,et al. Importance of the polarity of the glycosaminoglycan chain on the interaction with FGF-1. , 2014, Glycobiology.
[7] G. Torri,et al. Antithrombin-binding oligosaccharides: structural diversities in a unique function? , 2014, Glycoconjugate Journal.
[8] Yassir A. Ahmed,et al. Characterisation of the interaction of neuropilin-1 with heparin and a heparan sulfate mimetic library of heparin-derived sugars , 2014, PeerJ.
[9] J. Esko,et al. Demystifying heparan sulfate-protein interactions. , 2014, Annual review of biochemistry.
[10] E. Yates,et al. A heparin-like glycosaminoglycan from shrimp containing high levels of 3-O-sulfated D-glucosamine groups in an unusual trisaccharide sequence. , 2014, Carbohydrate research.
[11] R. Linhardt,et al. Capillary electrophoresis for total glycosaminoglycan analysis , 2014, Analytical and Bioanalytical Chemistry.
[12] Sylvie Ricard-Blum,et al. Heparin-protein interactions: from affinity and kinetics to biological roles. Application to an interaction network regulating angiogenesis. , 2014, Matrix biology : journal of the International Society for Matrix Biology.
[13] R. Linhardt,et al. Fibroblast Growth Factor-based Signaling through Synthetic Heparan Sulfate Blocks Copolymers Studied Using High Cell Density Three-dimensional Cell Printing* , 2014, The Journal of Biological Chemistry.
[14] J. Zaia,et al. Brittlestars contain highly sulfated chondroitin sulfates/dermatan sulfates that promote fibroblast growth factor 2-induced cell signaling. , 2014, Glycobiology.
[15] E. Yates,et al. A non-hemorrhagic hybrid heparin/heparan sulfate with anticoagulant potential. , 2014, Carbohydrate polymers.
[16] Q. Nunes,et al. The heparin-binding protein interactome in pancreatic diseases. , 2013, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].
[17] S. Perkins,et al. The solution structure of heparan sulfate differs from that of heparin. IMPLICATIONS FOR FUNCTION. , 2013, The Journal of Biological Chemistry.
[18] J. Zaia,et al. Heparan sulfate-protein binding specificity , 2013, Biochemistry (Moscow).
[19] J. Leary,et al. Method development and analysis of free HS and HS in proteoglycans from pre- and postmenopausal women: evidence for biosynthetic pathway changes in sulfotransferase and sulfatase enzymes. , 2013, Analytical chemistry.
[20] Jian Liu,et al. An approach for separation and complete structural sequencing of heparin/heparan sulfate-like oligosaccharides. , 2013, Analytical chemistry.
[21] J. Zaia,et al. Comparative glycomics of leukocyte glycosaminoglycans , 2013, The FEBS journal.
[22] D. Fernig,et al. Analysis of the fibroblast growth factor receptor (FGFR) signalling network with heparin as coreceptor: evidence for the expansion of the core FGFR signalling network , 2013, The FEBS journal.
[23] E. Yates,et al. Antithrombin stabilisation by sulfated carbohydrates correlates with anticoagulant activity , 2013 .
[24] Yunliang Chen,et al. Perturbation of the heparin/heparin-sulfate interactome of human breast cancer cells modulates pro-tumourigenic effects associated with PI3K/Akt and MAPK/ERK signalling , 2013, Thrombosis and Haemostasis.
[25] M. G. Maragheh,et al. Evaluate of heavy metal concentration in shrimp (Penaeus semisulcatus) and crab (Portunus pelagicus) with INAA method , 2013, SpringerPlus.
[26] Paul L. Dubin,et al. Protein–polyelectrolyte interactions , 2013 .
[27] C. Boudier,et al. An unusual antithrombin-binding heparin octasaccharide with an additional 3-O-sulfated glucosamine in the active pentasaccharide sequence. , 2013, The Biochemical journal.
[28] S. Hung,et al. Divergent synthesis of 48 heparan sulfate-based disaccharides and probing the specific sugar-fibroblast growth factor-1 interaction. , 2012, Journal of the American Chemical Society.
[29] G. Kellogg,et al. On the Specificity of Heparin/Heparan Sulfate Binding to Proteins. Anion-Binding Sites on Antithrombin and Thrombin Are Fundamentally Different , 2012, PloS one.
[30] Yassir A. Ahmed,et al. Diversification of the Structural Determinants of Fibroblast Growth Factor-Heparin Interactions , 2012, The Journal of Biological Chemistry.
[31] Yongmei Xu,et al. Chemoenzymatic Synthesis of Heparin Oligosaccharides with both Anti-factor Xa and Anti-factor IIa Activities* , 2012, The Journal of Biological Chemistry.
[32] I. Prior,et al. Transport of Fibroblast Growth Factor 2 in the Pericellular Matrix Is Controlled by the Spatial Distribution of Its Binding Sites in Heparan Sulfate , 2012, PLoS biology.
[33] C. Tucker,et al. Fundamental differences in model cell-surface polysaccharides revealed by complementary optical and spectroscopic techniques , 2012 .
[34] Yongmei Xu,et al. Chemoenzymatic synthesis of heparan sulfate and heparin. , 2014, Natural product reports.
[35] E. Yates,et al. A highly efficient tree structure for the biosynthesis of heparan sulfate accounts for the commonly observed disaccharides and suggests a mechanism for domain synthesis. , 2012, Molecular bioSystems.
[36] H. Nader,et al. Chemical reduction of carboxyl groups in heparin abolishes its vasodilatory activity , 2012, Journal of cellular biochemistry.
[37] M. Fini,et al. Heparin-like heparan sulfate from rabbit cartilage. , 2012, Glycobiology.
[38] N. Leymarie,et al. Highly Sulfated Nonreducing End-derived Heparan Sulfate Domains Bind Fibroblast Growth Factor-2 with High Affinity and Are Enriched in Biologically Active Fractions* , 2011, The Journal of Biological Chemistry.
[39] P. Seeberger,et al. Characterization of annexin A1 glycan binding reveals binding to highly sulfated glycans with preference for highly sulfated heparan sulfate and heparin. , 2011, Biochemistry.
[40] A. Ori,et al. A Systems Biology Approach for the Investigation of the Heparin/Heparan Sulfate Interactome* , 2011, The Journal of Biological Chemistry.
[41] M. Hricovíni. Effect of solvent and counterions upon structure and NMR spin-spin coupling constants in heparin disaccharide. , 2011, The journal of physical chemistry. B.
[42] A. Ori,et al. Comparable stabilisation, structural changes and activities can be induced in FGF by a variety of HS and non-GAG analogues: implications for sequence-activity relationships. , 2010, Organic & biomolecular chemistry.
[43] E. Yates,et al. The latent ampholytic nature of glycosaminoglycan (GAG) oligosaccharides facilitates their separation by isoelectric focusing , 2010 .
[44] P. Dubin,et al. Glycosaminoglycans as polyelectrolytes. , 2010, Advances in colloid and interface science.
[45] D. Spillmann,et al. Heparan Sulfate Domain Organization and Sulfation Modulate FGF-induced Cell Signaling* , 2010, The Journal of Biological Chemistry.
[46] E. Yates,et al. Conformational degeneracy restricts the effective information content of heparan sulfate. , 2010, Molecular bioSystems.
[47] Yassir A. Ahmed,et al. Generating heparan sulfate saccharide libraries for glycomics applications , 2010, Nature Protocols.
[48] Jayesh Gor,et al. Semi-rigid solution structures of heparin by constrained X-ray scattering modelling: new insight into heparin-protein complexes. , 2010, Journal of molecular biology.
[49] H. Nader,et al. Heparan sulfate proteoglycans: structure, protein interactions and cell signaling. , 2009, Anais da Academia Brasileira de Ciencias.
[50] A. Ori,et al. Cations modulate polysaccharide structure to determine FGF-FGFR signaling: a comparison of signaling and inhibitory polysaccharide interactions with FGF-1 in solution. , 2009, Biochemistry.
[51] Umesh R Desai,et al. Interaction of Antithrombin with Sulfated, Low Molecular Weight Lignins , 2009, The Journal of Biological Chemistry.
[52] Jamie M. Verheyden,et al. FGF-regulated Etv genes are essential for repressing Shh expression in mouse limb buds. , 2009, Developmental cell.
[53] T. Dierks,et al. Sulf Loss Influences N-, 2-O-, and 6-O-Sulfation of Multiple Heparan Sulfate Proteoglycans and Modulates Fibroblast Growth Factor Signaling* , 2008, Journal of Biological Chemistry.
[54] Kimberly Forsten-Williams,et al. Control of Growth Factor Networks by Heparan Sulfate Proteoglycans , 2008, Annals of Biomedical Engineering.
[55] C. Boudier,et al. Antithrombin-binding Octasaccharides and Role of Extensions of the Active Pentasaccharide Sequence in the Specificity and Strength of Interaction , 2008, Journal of Biological Chemistry.
[56] D. Clarke,et al. Site-specific interactions of copper(II) ions with heparin revealed with complementary (SRCD, NMR, FTIR and EPR) spectroscopic techniques. , 2008, Carbohydrate research.
[57] A. Ori,et al. The heparanome and regulation of cell function: structures, functions and challenges. , 2008, Frontiers in bioscience : a journal and virtual library.
[58] D. Clarke,et al. Influence of substitution pattern and cation binding on conformation and activity in heparin derivatives. , 2007, Glycobiology.
[59] S. Werner,et al. Potentiation of fibroblast growth factor activity by synthetic heparin oligosaccharide glycodendrimers. , 2007, Chemistry & biology.
[60] P. Dubin,et al. Nonspecific electrostatic binding characteristics of the heparin-antithrombin interaction. , 2007, Biopolymers.
[61] Thomas Dierks,et al. The heparanome--the enigma of encoding and decoding heparan sulfate sulfation. , 2007, Journal of biotechnology.
[62] Diane J. Rodi,et al. X-ray fluorescence microscopy reveals large-scale relocalization and extracellular translocation of cellular copper during angiogenesis , 2007, Proceedings of the National Academy of Sciences.
[63] A. Dell,et al. N-Glycosylation of Fibroblast Growth Factor Receptor 1 Regulates Ligand and Heparan Sulfate Co-receptor Binding* , 2006, Journal of Biological Chemistry.
[64] M. Pardue,et al. The Journal of Cell Biology , 2002 .
[65] T. Peretz,et al. Heparanase promotes growth, angiogenesis and survival of primary breast tumors , 2006, International journal of cancer.
[66] Serge Pérez,et al. Prospects for glycoinformatics. , 2005, Current opinion in structural biology.
[67] M. Nugent,et al. Identification of common and specific growth factor binding sites in heparan sulfate proteoglycans. , 2005, Biochemistry.
[68] P. Dubin,et al. Characterization of polyanion-protein complexes by frontal analysis continuous capillary electrophoresis and small angle neutron scattering: effect of polyanion flexibility. , 2005, Analytical biochemistry.
[69] P. Jemth,et al. Fibroblast growth factors share binding sites in heparan sulphate. , 2005, The Biochemical journal.
[70] I. Vlodavsky,et al. In vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[71] R. Linhardt,et al. Structural characterization of human liver heparan sulfate. , 2005, Biochimica et biophysica acta.
[72] T. Peretz,et al. Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis. , 2004, Journal of the National Cancer Institute.
[73] S. Oscarson,et al. Irreversible Glucuronyl C5-epimerization in the Biosynthesis of Heparan Sulfate* , 2004, Journal of Biological Chemistry.
[74] J. Kiss,et al. VEGF is a chemoattractant for FGF-2–stimulated neural progenitors , 2003, The Journal of cell biology.
[75] L. Bain,et al. Altered expression of sulfotransferases, glucuronosyltransferases and mrp transporters in FVB/mrp1–/– mice , 2003, Xenobiotica; the fate of foreign compounds in biological systems.
[76] B. L. Allen,et al. Spatial and temporal expression of heparan sulfate in mouse development regulates FGF and FGF receptor assembly , 2003, The Journal of cell biology.
[77] J. Huntington,et al. Crystal structure of antithrombin in a heparin-bound intermediate state. , 2003, Biochemistry.
[78] M. Lyon,et al. Hepatocyte growth factor/scatter factor and its interaction with heparan sulphate and dermatan sulphate. , 2003, Biochemical Society transactions.
[79] C. Tribet,et al. Ionic strength dependence of protein-polyelectrolyte interactions. , 2003, Biomacromolecules.
[80] P. Jemth,et al. Biosynthetic Oligosaccharide Libraries for Identification of Protein-binding Heparan Sulfate Motifs , 2002, The Journal of Biological Chemistry.
[81] M. Gasset,et al. Prion protein interaction with glycosaminoglycan occurs with the formation of oligomeric complexes stabilized by Cu(II) bridges. , 2002, Journal of molecular biology.
[82] D. Rabenstein. Heparin and heparan sulfate: structure and function. , 2002, Natural product reports.
[83] L. Lay,et al. Minimal heparin/heparan sulfate sequences for binding to fibroblast growth factor-1. , 2002, Biochemical and biophysical research communications.
[84] R. Linhardt,et al. Heparin-protein interactions. , 2002, Angewandte Chemie.
[85] D. Ron,et al. Differential Effects of Heparin Saccharides on the Formation of Specific Fibroblast Growth Factor (FGF) and FGF Receptor Complexes* , 2002, The Journal of Biological Chemistry.
[86] G. Giménez-Gallego,et al. Sequence Analysis of Heparan Sulfate Epitopes with Graded Affinities for Fibroblast Growth Factors 1 and 2* , 2001, The Journal of Biological Chemistry.
[87] J. Gallagher. Heparan sulfate: growth control with a restricted sequence menu. , 2001, The Journal of clinical investigation.
[88] J. Esko,et al. Molecular diversity of heparan sulfate. , 2001, The Journal of clinical investigation.
[89] B. Mulloy,et al. Characterization of Unfractionated Heparin: Comparison of Materials from the last 50 Years , 2000, Thrombosis and Haemostasis.
[90] M. Forster,et al. Conformation and dynamics of heparin and heparan sulfate. , 2000, Glycobiology.
[91] R. Vivès,et al. Regulation of FGF-1 mitogenic activity by heparan sulfate oligosaccharides is dependent on specific structural features: differential requirements for the modulation of FGF-1 and FGF-2. , 2000, Glycobiology.
[92] David F. Burke,et al. Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin , 2000, Nature.
[93] B. Snel,et al. STRING: a web-server to retrieve and display the repeatedly occurring neighbourhood of a gene. , 2000, Nucleic acids research.
[94] J. Schlessinger,et al. Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. , 2000, Molecular cell.
[95] H. Nader,et al. A novel heparan sulphate with high degree of N-sulphation and high heparin cofactor-II activity from the brine shrimp Artemia franciscana. , 2000, International journal of biological macromolecules.
[96] A. Friedl,et al. Differential ability of heparan sulfate proteoglycans to assemble the fibroblast growth factor receptor complex in situ , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[97] J. Turnbull,et al. Fibroblast growth factor receptor signalling is dictated by specific heparan sulphate saccharides , 1999, Current Biology.
[98] S. Stringer,et al. Heparin Is a Unique Marker of Progenitors in the Glial Cell Lineage* , 1999, The Journal of Biological Chemistry.
[99] P. Gorin,et al. Structural features and anticoagulant activities of a novel natural low molecular weight heparin from the shrimp Penaeus brasiliensis. , 1999, Biochimica et biophysica acta.
[100] R. Pettersson,et al. Characterization of fibroblast growth factor 1 binding heparan sulfate domain. , 1999, Glycobiology.
[101] B. Seaton,et al. Interaction of heparin with annexin V , 1999, FEBS letters.
[102] D. Hart,et al. The salt dependence of DNA recognition by NF-kappaB p50: a detailed kinetic analysis of the effects on affinityand specificity. , 1999, Nucleic acids research.
[103] M. Porcionatto,et al. Stimulation of heparan sulfate proteoglycan synthesis and secretion during G1 phase induced by growth factors and PMA , 1998, Journal of cellular biochemistry.
[104] J. Turnbull,et al. Heparan Sulfate Oligosaccharides Require 6-O-Sulfation for Promotion of Basic Fibroblast Growth Factor Mitogenic Activity* , 1998, The Journal of Biological Chemistry.
[105] U. Desai,et al. Mechanism of heparin activation of antithrombin: evidence for an induced-fit model of allosteric activation involving two interaction subsites. , 1998, Biochemistry.
[106] M. Porcionatto,et al. Structure of heparan sulfate: identification of variable and constant oligosaccharide domains in eight heparan sulfates of different origins. , 1998, Cellular and molecular biology.
[107] P. Rudland,et al. Interactions of putative heparin-binding domains of basic fibroblast growth factor and its receptor, FGFR-1, with heparin using synthetic peptides , 1998, Glycoconjugate Journal.
[108] P. Rudland,et al. Interaction of Heparan Sulfate from Mammary Cells with Acidic Fibroblast Growth Factor (FGF) and Basic FGF , 1998, The Journal of Biological Chemistry.
[109] J. Hirsh,et al. Effect of nonspecific binding to plasma proteins on the antithrombin activities of unfractionated heparin, low-molecular-weight heparin, and dermatan sulfate. , 1997, Circulation.
[110] E. Yates,et al. 1H and 13C NMR spectral assignments of the major sequences of twelve systematically modified heparin derivatives. , 1996, Carbohydrate research.
[111] J. Gabriel,et al. Divalent Cations and Heparin/Heparan Sulfate Cooperate to Control Assembly and Activity of the Fibroblast Growth Factor Receptor Complex* , 1996, The Journal of Biological Chemistry.
[112] C. MacArthur,et al. Receptor Specificity of the Fibroblast Growth Factor Family* , 1996, The Journal of Biological Chemistry.
[113] G. Torri,et al. Characterization of sulfation patterns of beef and pig mucosal heparins by nuclear magnetic resonance spectroscopy. , 1996, Arzneimittel-Forschung.
[114] D C Rees,et al. Heparin Structure and Interactions with Basic Fibroblast Growth Factor , 1996, Science.
[115] J. Peng,et al. Multinuclear magnetic resonance studies of the interaction of inorganic cations with heparin. , 1995, Carbohydrate research.
[116] J. Weiler,et al. Differences in the interaction of heparin with arginine and lysine and the importance of these basic amino acids in the binding of heparin to acidic fibroblast growth factor. , 1995, Archives of biochemistry and biophysics.
[117] M. Porcionatto,et al. Heparan sulfate proteoglycan and control of cell proliferation: enhanced synthesis induced by phorbol ester (PMA) during G(1)-phase. , 1994, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[118] J. Turnbull,et al. Cell surface syndecan-1 on distinct cell types differs in fine structure and ligand binding of its heparan sulfate chains. , 1994, The Journal of biological chemistry.
[119] M. Lyon,et al. Liver heparan sulfate structure. A novel molecular design. , 1994, The Journal of biological chemistry.
[120] M. Pantoliano,et al. Energetic characterization of the basic fibroblast growth factor-heparin interaction: identification of the heparin binding domain. , 1994, Biochemistry.
[121] G. Hortin,et al. Interference in ionized calcium measurements by heparin salts. , 1994, Clinical chemistry.
[122] J. Turnbull,et al. Specific heparan sulfate saccharides mediate the activity of basic fibroblast growth factor. , 1994, The Journal of biological chemistry.
[123] B. Olwin,et al. Activating and inhibitory heparin sequences for FGF-2 (basic FGF). Distinct requirements for FGF-1, FGF-2, and FGF-4. , 1993, The Journal of biological chemistry.
[124] Â. Gambarini,et al. Mitogenic activity of acidic fibroblast growth factor is enhanced by highly sulfated oligosaccharides derived from heparin and heparan sulfate , 1993, Molecular and Cellular Biochemistry.
[125] J. Turnbull,et al. Heparan sulphate: functional role as a modulator of fibroblast growth factor activity. , 1993, Biochemical Society transactions.
[126] S. Pizzo,et al. Ionic modulation of the effects of heparin on plasminogen activation by tissue plasminogen activator: the effects of ionic strength, divalent cations, and chloride. , 1992, Archives of biochemistry and biophysics.
[127] D. Grant,et al. A potentiometric titration study of the interaction of heparin with metal cations. , 1992, The Biochemical journal.
[128] J. Turnbull,et al. Identification of the basic fibroblast growth factor binding sequence in fibroblast heparan sulfate. , 1992, The Journal of biological chemistry.
[129] R. Rej,et al. Sulfation of some chemically-modified heparins. Formation of a 3-sulfate analog of heparin. , 1991, Carbohydrate research.
[130] B. Casu,et al. Structure of Heparin and Heparin Fragments , 1989, Annals of the New York Academy of Sciences.
[131] D. Atha,et al. Contribution of 3-O- and 6-O-sulfated glucosamine residues in the heparin-induced conformational change in antithrombin III. , 1987, Biochemistry.
[132] H. Nader,et al. Heparin sequences in the heparan sulfate chains of an endothelial cell proteoglycan. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[133] H. Nader,et al. Lack of correlation between "in vitro" and "in vivo" antithrombotic activity of heparin fractions and related compounds. Heparan sulfate as an antithrombotic agent "in vivo". , 1985, Thrombosis research.
[134] D. Atha,et al. Contribution of monosaccharide residues in heparin binding to antithrombin III. , 1985, Biochemistry.
[135] J. Gallagher,et al. Molecular distinctions between heparan sulphate and heparin. Analysis of sulphation patterns indicates that heparan sulphate and heparin are separate families of N-sulphated polysaccharides. , 1985, The Biochemical journal.
[136] H. Nader,et al. An inverse relationship between heparin content and antibody response in genetically selected mice. Sex effect and evidence of a polygenic control for skin heparin concentration. , 1984, The Biochemical journal.
[137] P. Gullino,et al. Angiogenesis in vivo and selective mobilization of capillary endothelium in vitro by heparin-copper complex. , 1984, Microcirculation, endothelium, and lymphatics.
[138] A. Sartorelli,et al. Incorporation of 35S-sulfate and 3H-glucosamine into heparan and chondroitin sulfates during the cell cycle of B16-F10 cells. , 1984, Cytometry.
[139] M. Griffith,et al. Calcium inhibits the heparin-catalyzed antithrombin III/thrombin reaction by decreasing the apparent binding affinity of heparin for thrombin. , 1983, Archives of biochemistry and biophysics.
[140] H. Magdelenat,et al. Effect of ionic strength on the diffusion coefficient of chondroitin sulfate and heparin measured by quasielastic light scattering , 1983 .
[141] P. Ander,et al. Sodium ion diffusion in aqueous salt-free heparin solutions , 1981 .
[142] R. Rosenberg,et al. Correlation between structure and function of heparin. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[143] G. S. Manning. The molecular theory of polyelectrolyte solutions with applications to the electrostatic properties of polynucleotides , 1978, Quarterly Reviews of Biophysics.
[144] H. Nader,et al. The heterogeneity of heparan sulfate from beef-lung tissue: p.m.r.-spectral evidence. , 1975, Carbohydrate research.
[145] R. Tobey,et al. CELL-CYCLE DEPENDENT DESQUAMATION OF HEPARAN SULFATE FROM THE CELL SURFACE , 1972, The Journal of cell biology.
[146] D. Mackie,et al. Evidence for a (1→4)-linked 4-O-(α-L-idopyranosyluronic acid 2-sulfate)-(2-deoxy-2-sulfoamino-D-glucopyranosyl 6-sulfate) sequence in heparin , 1971 .
[147] D. F. Koenig,et al. Structure of Hen Egg-White Lysozyme: A Three-dimensional Fourier Synthesis at 2 Å Resolution , 1965, Nature.
[148] C. Boudier,et al. Heparin Dodecasaccharide Containing Two Antithrombin-binding Pentasaccharides STRUCTURAL FEATURES AND BIOLOGICAL PROPERTIES , 2013 .
[149] U. Lindahl,et al. Interactions between heparan sulfate and proteins-design and functional implications. , 2009, International review of cell and molecular biology.
[150] B. Mulloy. The specificity of interactions between proteins and sulfated polysaccharides. , 2005, Anais da Academia Brasileira de Ciencias.
[151] J. Turnbull,et al. Highly diverse heparan sulfate analogue libraries: providing access to expanded areas of sequence space for bioactivity screening. , 2004, Journal of Medicinal Chemistry.
[152] J. Angulo,et al. The heparin-Ca(2+) interaction: Structure of the Ca(2+) binding site , 2002 .
[153] B. Seaton,et al. Annexin V--heparin oligosaccharide complex suggests heparan sulfate--mediated assembly on cell surfaces. , 2001, Structure.
[154] S. Guimond,et al. Heparan sulfate: decoding a dynamic multifunctional cell regulator. , 2001, Trends in cell biology.
[155] U Lindahl,et al. Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor. , 1994, The Journal of biological chemistry.
[156] H. Kingdon,et al. Effect of monovalent cations on the heparin-enhanced antithrombin III/thrombin reaction. , 1980, Thrombosis research.
[157] Y. Inoue,et al. Selective N-desulfation of heparin with dimethyl sulfoxide containing water or methanol. , 1976, Carbohydrate research.
[158] D. Mackie,et al. Evidence for a (1 leads to 4)-linked 4-O-( -L-idopyranosyluronic acid 2-sulfate)-(2-deoxy-2-sulfoamino-D-glucopyranosyl 6-sulfate) sequence in heparin. Long-range H-H coupling in 4-deoxy-hex-4-enopyranosides. , 1971, Carbohydrate research.